|
Title
|
|
|
|
Response to : the use of guidelines to assess the risk of malignant hyperthermia in individuals with a RYR1 variant
|
|
|
Author
|
|
|
|
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Neuromuscular disorders
|
|
|
Publication
|
|
|
|
Oxford
:
Pergamon-elsevier science ltd
,
2024
|
|
|
ISSN
|
|
|
|
0960-8966
|
|
|
DOI
|
|
|
|
10.1016/J.NMD.2023.11.007
|
|
|
Volume/pages
|
|
|
|
35
(2024)
, p. 39
|
|
|
ISI
|
|
|
|
001168910500001
|
|
|
Pubmed ID
|
|
|
|
38237271
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|